Chief Technology Officer · Candel Therapeutics, Inc. · Common Stock
Side
SELL
Value
$84K
Shares
7,000
Price
$12
Executed
Aug 17, 2026
Disclosed
Aug 19, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 17 executedAug 19, 2026 disclosed
CADL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Tyagarajan Seshu filed this Form 4 reporting a open-market sale of CADL on Aug 17, 2026. It became public on Aug 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Technology Officer
Tyagarajan Seshucik:0001923794
Issuer
Candel Therapeutics, Inc.cik:0001841387
Revision history · 0
No field has changed since this record was first ingested.
